Clinical Trials List
2009-05-01 - 2015-09-30
Phase III
Terminated9
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 許榮彬 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡政廷 Division of Cardiovascular Diseases
- 張盛雄 Division of Cardiovascular Diseases
- 吳懿哲 Division of Cardiovascular Diseases
- 洪祟烈 Division of Cardiovascular Diseases
- 蔡瑞鵬 Division of Cardiovascular Diseases
- Ping-Ing Lee Division of Cardiovascular Diseases
- 羅志賢 Division of Cardiovascular Diseases
- 顏志軒 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shih-Sheng Chang Division of Cardiovascular Diseases
- 陳恬恩 Division of Cardiovascular Diseases
- 張志斌 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Cheng-Han Lee Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳勉成 Division of Cardiovascular Diseases
- 陳建仁 Division of Cardiovascular Diseases
- 蔡子賢 Division of Cardiovascular Diseases
- 蔡慧玲 Division of Cardiovascular Diseases
- 楊正旭 Division of Cardiovascular Diseases
- 劉文浩 Division of Cardiovascular Diseases
- 吳明謙 Division of Cardiovascular Diseases
- 洪志凌 Division of Cardiovascular Diseases
- 傅懋洋 Division of Cardiovascular Diseases
- 薛書凱 Division of Cardiovascular Diseases
- 葉漢根 Division of Cardiovascular Diseases
- 郭必芳 Division of Cardiovascular Diseases
- 吳炯仁 Division of Cardiovascular Diseases
- 陳永隆 Division of Cardiovascular Diseases
- 柴漢東 Division of Cardiovascular Diseases
- 方志元 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 黃智興 Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- Hsiang Chun Lee Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 羅志賢 Division of Cardiovascular Diseases
- 顏志軒 Division of Cardiovascular Diseases
- Ping-Ing Lee Division of Cardiovascular Diseases
- 張盛雄 Division of Cardiovascular Diseases
- 蔡政廷 Division of Cardiovascular Diseases
- 洪祟烈 Division of Cardiovascular Diseases
- 吳懿哲 Division of Cardiovascular Diseases
- 蔡瑞鵬 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
7041 participants
